Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery | Last updated: March 13, 2026
Key Takeaways for GLP-1 and GLP-3R Weight Loss
- GLP-1 medications usually lead to 0–2 pounds lost in weeks 1–2, mostly water. Weeks 3–8 average 1–2 pounds per week. Loss then slows to 0.5–1 pound per week, with 10–15% total body weight reduction at 6 months.
- Nausea and other side effects peak in weeks 1–4. Use the 3-3-3 rule: if you do not lose 3% of body weight after 3 months on 3 dose increases, your provider should reassess treatment.
- Results depend on BMI, diet, exercise, age, and lab values. Exercise protects muscle and can prevent up to 40% of total loss from being muscle.
- GLP-3R peptides outperform GLP-1s, with 2.5 kg more loss at 6 months, 82% muscle retention, fewer side effects, and faster early results.
- For a customized GLP-3R plan with medical supervision, book a consultation at Mirror Plastic Surgery with Ellie Pranckevicius.
Meet Your Nurse Practitioner: Ellie Pranckevicius
Ellie Pranckevicius, FNP-BC, leads Mirror Plastic Surgery’s peptide therapy program with both aesthetic expertise and advanced clinical training. She earned her Bachelor’s in Health Science from Boston University on the premedical track, completed a rigorous aesthetics licensure program, and obtained both her Bachelor’s and Master’s in Nursing from the University of South Florida. Her four years in the Neuroscience ICU at Tampa General Hospital gave her critical-care experience managing complex patients with a deep understanding of physiology, metabolic health, and recovery.
Ellie combines esthetician training with board-certified Family Nurse Practitioner credentials. She understands the cosmetic goals patients want and the medical science required to reach them safely and effectively. She focuses on clear education and honesty so you understand what you are taking and why. She works closely with Dr. Akash Chandawarkar, a Harvard-educated physician and Johns Hopkins-trained plastic surgeon with fellowship training in aesthetic surgery at Manhattan Eye Ear & Throat Hospital (MEETH)/Lenox Hill Hospital and medical innovation training at Stanford University.
Week-by-Week GLP-1 Weight Loss Expectations
Real-world clinical data outlines a predictable pattern during GLP-1 therapy. The OASIS 4 phase 3 trial showed higher rates of at least 15% body weight reduction with semaglutide, and a 2026 network meta-analysis found semaglutide produced a mean difference of -10.53% weight reduction versus placebo.
| Week Range | Expected Weight Loss | Key Changes | Common Side Effects |
|---|---|---|---|
| Weeks 1-2 | 0-2 lbs (mostly water) | Reduced appetite, “food noise” quieting | Nausea (20-40%), mild GI discomfort |
| Weeks 3-4 | 1-2 lbs per week | Fat loss begins, portion control feels easier | Nausea peaks, constipation possible |
| Weeks 5-8 | 1-2 lbs per week | Steady fat loss, stronger satiety | GI side effects usually improve |
| Weeks 9-16 | 0.5-1.5 lbs per week | Consistent loss, some metabolic adaptation | Minimal side effects, possible plateau |
| Weeks 17-26 | 0.5-1 lb per week | Slower but steady progress | Rare side effects, plateaus common |
| 6 months | 10-15% total loss | Meaningful metabolic improvements | Generally well tolerated, lifestyle dependent |
| 12 months | 12-20% total loss | Maximum benefit reached for most | Long-term sustainability varies |
Clinical trials show mean weight loss differences versus placebo of -13.1% for injectable semaglutide and -11.4% for oral forms. Individual outcomes still vary based on adherence, lifestyle, and starting weight.
Key Factors That Shape Your GLP-1 Results
Several personal and medical factors influence how well GLP-1 medications work and how quickly results appear. The STEP 1 trial found that participants with BMI ≥35 lost about 15–17% of body weight at 68 weeks, compared with lower losses in those with BMI <30. Important factors include:
- Dosage progression: Gradual titration from 0.25 mg to 2.4 mg weekly shapes both results and side effects.
- Starting BMI: Higher baseline BMI usually produces greater absolute pounds lost, even at similar percentage loss.
- Diet adherence: A reduced-calorie, protein-forward diet strongly supports sustained fat loss.
- Exercise integration: Exercise preserved lean muscle mass and improved long-term maintenance; without it, up to 40% of loss came from muscle.
- Age and metabolism: Age over 50 and female sex were linked to slower loss but better maintenance when paired with resistance training.
- Laboratory findings: Thyroid function, insulin levels, and hormones can speed or slow progress.
Mirror Plastic Surgery uses comprehensive lab testing to identify these variables and shape your protocol from day one.
Managing Side Effects, Plateaus, and the 3-3-3 Rule
Nausea is the most common adverse effect, with rates between 20% and 40% depending on the medication and dose. Overall GI adverse event rates with GLP-1RAs reach 11.66%, with nausea at 21.49%. Symptoms usually appear in weeks 1–4 and around dose increases.
The 3-3-3 rule helps flag treatment failure. If you have not lost at least 3% of your body weight after 3 months on 3 consecutive dose increases, the medication may not be the right fit. Weight loss plateaus are common and often feel frustrating. A 2024 Lancet study showed that a high-protein diet above 1.2 g/kg body weight combined with GLP-1 improved fat loss over muscle loss, with 75% of patients maintaining more than 10% loss at 1 year.
A 200-pound person usually needs 3–6 months of consistent use to lose about 20 pounds. Helpful plateau strategies include raising protein intake, adding or increasing resistance training, and improving sleep quality.
GLP-3R at Mirror: A Next-Generation Peptide Option
Newer GLP-3R peptide formulations often provide stronger and more comfortable results than traditional GLP-1 medications. A 2026 meta-analysis of five randomized controlled trials found that GLP-3R produced 2.5 kg more weight loss at 6 months than GLP-1. GLP-3R groups also retained 82% of lean mass, compared with 65% in GLP-1 groups.
GLP-3R peptides offer several clear advantages over standard GLP-1 medications:
- Reduced side effects: Lower discontinuation rates of 8% versus 18% due to fewer GI symptoms.
- Faster early results: About 4% weight reduction at week 4 with GLP-3R compared with 2.5% for GLP-1.
- Better muscle preservation: Combined GIP and glucagon receptor activity helps limit muscle loss.
- Cardiovascular support: Broader metabolic improvements beyond the number on the scale.
Mirror Plastic Surgery offers compounded GLP-3R formulations tailored to your lab results and health history. One patient described noticeable water loss in the first week, followed by steady fat loss without the nausea they felt on prior GLP-1 therapy. Book an appointment with Ellie Pranckevicius to explore a personalized GLP-3R plan.
Why Patients Choose Mirror Plastic Surgery for Peptide Therapy
Mirror Plastic Surgery uses a concierge model for peptide therapy rather than a high-volume, one-size-fits-all approach. Ellie provides 24/7 text support, detailed lab analysis, and protocols that adjust as your body and goals change. The practice sources peptides from vetted providers that use strict batch testing to support safety in a largely unregulated space.
Each protocol reflects your physiology, goals, and lifestyle instead of a generic template. Mirror serves patients remotely across the United States, including Hawaii and Alaska, so you can access expert guidance from almost anywhere. Book an appointment with Ellie Pranckevicius to begin a personalized weight loss plan.
Contact the office at 727-361-6515, email hello@mirrorplasticsurgery.com, or visit 780 4th Ave S, St. Petersburg, FL 33701. Follow @mirrorplasticsurgery on Instagram for education, updates, and patient stories.
Frequently Asked Questions About GLP-1 and GLP-3R
What are the first signs that GLP-1 is working?
The earliest sign usually involves a quieter appetite and less “food noise,” meaning fewer constant thoughts about food. Many patients notice this within the first week. You may feel full with smaller portions and snack less between meals. Visible scale changes often begin in weeks 2–3, starting with water loss and then shifting toward fat loss.
How much weight loss can I expect week by week on GLP-1?
Most patients see 0–2 pounds of mostly water loss in weeks 1–2. Weeks 3–4 usually bring 1–2 pounds per week of more consistent fat loss, which often continues through week 8. After week 8, loss typically slows to 0.5–1.5 pounds per week as your metabolism adapts. By 6 months, many patients reach 10–15% total body weight reduction, with peak benefit around 12 months.
Why do people plateau on GLP-1 medications?
Plateaus often come from metabolic adaptation, muscle loss, and subtle lifestyle drift. As you lose weight, your body needs fewer calories, so the same intake leads to slower loss. Without enough protein and resistance training, up to 40% of lost weight can be muscle, which further slows metabolism. Some patients also eat slightly more or move less once side effects ease, which can stall progress.
How does GLP-3R compare to traditional GLP-1 medications?
GLP-3R peptides typically deliver 2.5 kg more weight loss at 6 months than GLP-1 medications, with 82% muscle retention versus 65%. Discontinuation rates are lower at about 8% compared with 18% for GLP-1s, largely due to fewer side effects. GLP-3R also tends to produce faster early loss and broader metabolic and cardiovascular benefits. At Mirror, GLP-3R protocols can be tailored to your lab results and health profile.
Are peptides FDA-approved and how do results vary?
Many peptides, including most GLP-3R formulations, are not FDA-regulated, so medical oversight is essential for safety and effective dosing. Results vary widely based on genetics, starting weight, diet, exercise, age, hormones, and other health conditions. Personalized protocols matter because a dose or combination that works well for one person may underperform or cause side effects in another. Mirror Plastic Surgery uses comprehensive labs and close follow-up to refine treatment for each individual.
Next Steps: Start a Personalized Peptide Plan
Clear expectations about GLP-1 timelines help you stay consistent while you consider advanced options like GLP-3R. GLP-3R peptides can provide stronger results, fewer side effects, and better muscle preservation than traditional GLP-1 medications. Mirror Plastic Surgery supports these therapies with individualized protocols and close clinical supervision. Schedule your consultation with Ellie Pranckevicius to begin a medically guided peptide program.
Disclaimer: Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Disclaimer: Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
